Clene Inc. (CLNN): Total Liabilities
$35.72M
As of 2025-12-31
$47.82M
As of 2026-06-30
-4.7%
3-year compound annual growth
-12.1%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $35.72M | -1.3% | 2026-03-17, Balance as of period end |
| 2024-12-31 | $36.19M | -7.1% | 2026-03-17, Balance as of period end |
| 2023-12-31 | $38.95M | -5.6% | 2025-03-24, Balance as of period end |
| 2022-12-31 | $41.26M | -18.2% | 2024-03-13, Balance as of period end |
| 2021-12-31 | $50.47M | -25.7% | 2023-03-13, Balance as of period end |
| 2020-12-31 | $67.90M | +579.7% | 2022-03-11, Balance as of period end |
| 2019-12-31 | $9.99M | n/a | 2021-03-29, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Clene Inc. (CLNN) | 2025-12-31 | $35.72M | -1.3% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $3.14M | -44.7% |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | $6.56M | +21.9% |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | $7.76M | +13.9% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $6.99M | +12.4% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $2.74M | -52.6% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $8.43M | -22.2% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | $7.00M | +0.4% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $672.0K | +14.3% |
Compare CLNN, LSTA, RGBP, ABVC side by side · Screen every company in Pharmaceutical Preparations ↗